Bugtong, Lorena R.
HRN: 26-35-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2024
LEVOFLOXACIN 500MG (TAB)
12/29/2024
01/03/2025
PO
500 Mg
Od
Pleural Effusion
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes